{"disease":{"id":"severe-acute-respiratory-syndrome-coronavirus-2","name":"severe acute respiratory syndrome coronavirus 2"},"drugs":{"marketed":[{"drug_id":"remdesivir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Veklury","generic_name":"remdesivir","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"SARS-CoV-2 RNA polymerase","drug_class":"Nucleotide analog RNA polymerase inhibitor","quality_score":79,"revenue":"2200","mechanism":"Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2."},{"drug_id":"baricitinib","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Olumiant","generic_name":"baricitinib","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase JAK2","drug_class":"Janus Kinase Inhibitor [EPC]","quality_score":50,"revenue":"1200","mechanism":""},{"drug_id":"ensitrelvir","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xocova","generic_name":"ENSITRELVIR","company_name":"Shionogi & Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":24,"revenue":"400","mechanism":""},{"drug_id":"veklury","indication_name":"Disease caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Veklury","company_name":"ANRS, Emerging Infectious Diseases","drug_phase":"marketed","molecular_target":"NS5, Replicase polyprotein 1ab","drug_class":"Nucleoside analog prodrug","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"olumiant","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Olumiant","company_name":"NHS Greater Glasgow and Clyde","drug_phase":"marketed","molecular_target":"Casein kinase I isoform gamma-1, Citron Rho-interacting kinase, Mitogen-activated protein kinase kinase kinase 1","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"tocilizumab","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04349202","title":"Beaumont Health Large-scale Automated Serologic Testing for COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":20614,"lead_sponsor_name":"Corewell Health East","has_results":false},{"nct_id":"NCT05097677","title":"Follow-up of Covid-19 Long Term Sequelae","phase":"","overall_status":"COMPLETED","enrollment_count":7599,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Integrata Verona","has_results":false},{"nct_id":"NCT04367740","title":"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":6313,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT05458557","title":"Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus 2","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Elizabeth Glaser Pediatric AIDS Foundation","has_results":false},{"nct_id":"NCT05543616","title":"A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4292,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT04354779","title":"Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.","phase":"","overall_status":"COMPLETED","enrollment_count":3301,"lead_sponsor_name":"AUVA","has_results":false},{"nct_id":"NCT05629962","title":"SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2285,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04863547","title":"Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT04423770","title":"COVID-19 Related Health and Infection Control Practices Among Dentists","phase":"","overall_status":"COMPLETED","enrollment_count":2196,"lead_sponsor_name":"American Dental Association","has_results":false},{"nct_id":"NCT04367207","title":"African Covid-19 Critical Care Outcomes Study","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT04642638","title":"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":1307,"lead_sponsor_name":"Inovio Pharmaceuticals","has_results":true},{"nct_id":"NCT04611230","title":"A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois","phase":"","overall_status":"COMPLETED","enrollment_count":1007,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT05249816","title":"Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Cogna Technology Solutions LLC","has_results":false},{"nct_id":"NCT04519125","title":"Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":950,"lead_sponsor_name":"Hospital Universitario San Ignacio","has_results":false},{"nct_id":"NCT04732949","title":"Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Synairgen Research Ltd.","has_results":true},{"nct_id":"NCT04516811","title":"Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"South African National Blood Service","has_results":false},{"nct_id":"NCT04402879","title":"CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals","phase":"NA","overall_status":"UNKNOWN","enrollment_count":596,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04452565","title":"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":525,"lead_sponsor_name":"Biomed Industries, Inc.","has_results":false},{"nct_id":"NCT04847141","title":"A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":465,"lead_sponsor_name":"Grifols Therapeutics LLC","has_results":true},{"nct_id":"NCT04661631","title":"Surgery and Lung Ultrasound in COVID-19 Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":451,"lead_sponsor_name":"Fundacion Clinica Valle del Lili","has_results":false},{"nct_id":"NCT04711863","title":"Fluvoxamine for Adults With Mild to Moderate COVID-19","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":400,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT04958889","title":"COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV","phase":"","overall_status":"COMPLETED","enrollment_count":392,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04725084","title":"Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":355,"lead_sponsor_name":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","has_results":false},{"nct_id":"NCT04397588","title":"Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04602351","title":"Communication in ICU During COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":296,"lead_sponsor_name":"NMC Specialty Hospital","has_results":false},{"nct_id":"NCT04466241","title":"Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":294,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT04449276","title":"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"CureVac","has_results":true},{"nct_id":"NCT04588363","title":"COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04712110","title":"A Study of TAK-019 in Healthy Japanese Adults (COVID-19)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04987528","title":"Pulmonary Fibrosis During Severe COVID-19 Pneumonia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hôpital Européen Marseille","has_results":false},{"nct_id":"NCT04375176","title":"Monocytes and NK Cells Activity in Covid-19 Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Università degli Studi dell'Insubria","has_results":false},{"nct_id":"NCT05209009","title":"A Clinical Trial of COVAC-2 in Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT05947812","title":"A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":148,"lead_sponsor_name":"60P Australia Pty Ltd","has_results":false},{"nct_id":"NCT04357938","title":"Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections","phase":"","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT04343053","title":"Pro-thrombotic Status in Patients with SARS-Cov-2 Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT04376476","title":"Host-pathogen Interactions During SARS-CoV-2 Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05115045","title":"Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Hopital of Melun","has_results":false},{"nct_id":"NCT04667936","title":"Evaluation of Sedation in COVID-19 ARDS","phase":"","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Goethe University","has_results":false},{"nct_id":"NCT05197686","title":"Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT04365101","title":"Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":86,"lead_sponsor_name":"Celularity Incorporated","has_results":false},{"nct_id":"NCT04851821","title":"The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Hôpital Universitaire Sahloul","has_results":false},{"nct_id":"NCT04334044","title":"Treatment of SARS Caused by COVID-19 With Ruxolitinib","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Grupo Cooperativo de Hemopatías Malignas","has_results":false},{"nct_id":"NCT04402060","title":"A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04371978","title":"Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":64,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT04702178","title":"A Clinical Trial of COVAC-2 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"University of Saskatchewan","has_results":false},{"nct_id":"NCT06409663","title":"A Strain Change Study for SARS-CoV-2 rS Vaccines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Novavax","has_results":false},{"nct_id":"NCT04792021","title":"Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04375098","title":"Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Pontificia Universidad Catolica de Chile","has_results":false},{"nct_id":"NCT04409873","title":"Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":54,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT04379037","title":"Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Nemechek Technologies","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}